Australian academics round on ACTA

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Australian academics round on ACTA

A group of Australian academics has told a key parliamentary committee why they believe Australia should reconsider ratifying the controversial anti-counterfeiting treaty ACTA.

Law academics Kimberlee Weatherall of the University of Sydney and Matthew Rimmer from the Australian National University, and Hazel Moir of the Australian National University’s Centre for Policy Innovation spoke today at a public hearing into ACTA organised by the Federal Parliament’s Treaties Committee.

Rimmer told the hearing that he believed ACTA fails to provide safeguards in respect of human rights, consumer protection, competition, and privacy laws while Weatherall criticised the way the deal was negotiated and said that rights given to IP owners under ACTA had not been balanced by user rights of access.

Committee chair, Kelvin Thomson MP, said it was holding a second public hearing so the committee can gather as much information and perspectives as possible, given that ACTA has inspired such a level of protest.

“The committee understands that this is a controversial treaty nationally and internationally and is interested in hearing all points of view”, he said.

more from across site and SHARED ros bottom lb

More from across our site

Richard de Bodo, who had a lengthy career at international firms, shares how he will address client needs and praises the unique offerings of smaller firms
An Australian top court decision clarifying honest concurrent use and wins by publishers against AI platforms were also among the top talking points
AIPPI has pulled the plug on its planned 2027 World Congress, and INTA has delayed hosting a meeting there, but the concerns won’t abate
Despite being outspent by a wealthy opponent, a trial attorney at King & Spalding says ‘relentless pursuit of the truth’ helped his team secure a $420m damages award for mobile gaming client
190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo
Nokia, represented by a team from Bird & Bird, adjudged to have made fair offer to Asus and Acer in UK SEP dispute
Azhar Sadique and Kane Ridley, who founded the London office in 2023, are now both working in legal tech and AI-related roles, while another UK-based lawyer has also left
Partner Pierre Pérot rejoins the firm he left in 2022 alongside another returning lawyer, associate Camille Abba
Vaping dispute, in which Stobbs and Brandsmiths are the representatives, tested how the UK's Human Rights Act can apply to injunctions restraining unjustified threats
An AI platform being sold for £40m, and lateral hires involving law firms Womble Bond Dickinson and Cadwell Thomas were among the top talking points
Gift this article